Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ipilimumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ipilimumabmarket, defines the market attractiveness level of Ipilimumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ipilimumab industry, describes the types of Ipilimumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ipilimumab market and the development prospects and opportunities of Ipilimumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ipilimumab market in Chapter 13.
By Player:
Gilead
BMS
Prestige BioPharma
Baxter
Roche
Shenyang Sansheng Pharmaceutical
Avacta
Ono
By Type:
PD - L1 Antagonists
CTLA4 Antagonists
Immunocheckpoint Inhibitors
Other
By End-User:
Cancer
Melanoma
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ipilimumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ipilimumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ipilimumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ipilimumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ipilimumab Market Analysis and Outlook to 2022
-
7.1 Global Ipilimumab Consumption (2017-2022)
-
7.2 United States Ipilimumab Consumption (2017-2022)
-
7.3 Europe Ipilimumab Consumption (2017-2022)
-
7.4 China Ipilimumab Consumption (2017-2022)
-
7.5 Japan Ipilimumab Consumption (2017-2022)
-
7.6 India Ipilimumab Consumption (2017-2022)
-
7.7 South Korea Ipilimumab Consumption (2017-2022)
8 Region and Country-wise Ipilimumab Market Analysis and Outlook to 2028
-
8.1 Global Ipilimumab Consumption Forecast (2022-2028)
-
8.2 United States Ipilimumab Consumption Forecast (2022-2028)
-
8.3 Europe Ipilimumab Consumption Forecast (2022-2028)
-
8.4 China Ipilimumab Consumption Forecast (2022-2028)
-
8.5 Japan Ipilimumab Consumption Forecast (2022-2028)
-
8.6 India Ipilimumab Consumption Forecast (2022-2028)
-
8.7 South Korea Ipilimumab Consumption Forecast (2022-2028)
9 Global Ipilimumab Market Outlook by Types and Applications to 2022
-
9.1 Global Ipilimumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PD - L1 Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CTLA4 Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunocheckpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Ipilimumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Melanoma Consumption and Growth Rate (2017-2022)
10 Global Ipilimumab Market Outlook by Types and Applications to 2028
-
10.1 Global Ipilimumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PD - L1 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CTLA4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunocheckpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ipilimumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
11 Global Ipilimumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ipilimumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ipilimumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ipilimumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ipilimumab Market Competitive Analysis
-
14.1 Gilead
-
14.1.1 Gilead Company Details
-
14.1.2 Gilead Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Ipilimumab Product and Service
-
14.2 BMS
-
14.2.1 BMS Company Details
-
14.2.2 BMS Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BMS Ipilimumab Product and Service
-
14.3 Prestige BioPharma
-
14.3.1 Prestige BioPharma Company Details
-
14.3.2 Prestige BioPharma Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Prestige BioPharma Ipilimumab Product and Service
-
14.4 Baxter
-
14.4.1 Baxter Company Details
-
14.4.2 Baxter Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Baxter Ipilimumab Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Ipilimumab Product and Service
-
14.6 Shenyang Sansheng Pharmaceutical
-
14.6.1 Shenyang Sansheng Pharmaceutical Company Details
-
14.6.2 Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shenyang Sansheng Pharmaceutical Ipilimumab Product and Service
-
14.7 Avacta
-
14.7.1 Avacta Company Details
-
14.7.2 Avacta Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Avacta Ipilimumab Product and Service
-
14.8 Ono
-
14.8.1 Ono Company Details
-
14.8.2 Ono Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Ono Ipilimumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ipilimumab
-
Figure Ipilimumab Picture
-
Table Global Ipilimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ipilimumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ipilimumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ipilimumab Consumption by Country (2017-2022)
-
Figure United States Ipilimumab Consumption and Growth Rate (2017-2022)
-
Table Europe Ipilimumab Consumption and Growth Rate (2017-2022)
-
Figure China Ipilimumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Ipilimumab Consumption and Growth Rate (2017-2022)
-
Figure India Ipilimumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ipilimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Ipilimumab Consumption Forecast by Country (2022-2028)
-
Figure United States Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ipilimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PD - L1 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global CTLA4 Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Immunocheckpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global PD - L1 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTLA4 Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunocheckpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ipilimumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ipilimumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Ipilimumab Product and Service
-
Table BMS (Foundation Year, Company Profile and etc.)
-
Table BMS Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table BMS Ipilimumab Product and Service
-
Table Prestige BioPharma (Foundation Year, Company Profile and etc.)
-
Table Prestige BioPharma Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prestige BioPharma Ipilimumab Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Ipilimumab Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Ipilimumab Product and Service
-
Table Shenyang Sansheng Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenyang Sansheng Pharmaceutical Ipilimumab Product and Service
-
Table Avacta (Foundation Year, Company Profile and etc.)
-
Table Avacta Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avacta Ipilimumab Product and Service
-
Table Ono (Foundation Year, Company Profile and etc.)
-
Table Ono Ipilimumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Ipilimumab Product and Service
-
